Exopharm Limited

Unternehmensbeschreibung

Exopharm: Extending Health Span As its primary focus, Exopharm’s mission is to be a leader in the field of clinical human therapeutics using exosomes as regenerative medicine products. Exopharm is an Australian biopharmaceutical company that is seeking to develop and then commercialise exosomes as therapeutic agents – initially a product called Plexaris and later as a product called Exomeres – both being exosomes that are purified using the LEAP technology owned by Exopharm.

Überblick

NameExopharm Limited
SectorBiotech

IPO Daten

Datum19.12.2018
PreisAU$ 0,20
MarktkapitalAU$ 7.000.000
KürzelEX1
BörseAustralian Stock Exchange (ASX)
E-NEWSLETTER ABONNIERUNG
Abonnieren Sie unsere E-Mail-Liste, um über Updates und aktuelle Ankündigungen auf unserer Website informiert zu werden.
FOLGE SIE UNS
Vergissen Sie nicht, uns auf Social-Media-Seiten zu folgen